TrialJournal of the American Heart Association2016

Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.

Jamal N Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.